Page last updated: 2024-09-04

sabarubicin and Prostatic Neoplasms

sabarubicin has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bloch, J; Collette, L; Fargeot, P; Fiedler, W; Lacombe, D; Sorio, R; Tchen, N; Twelves, C; Vermorken, JB	1

Trials

1 trial(s) available for sabarubicin and Prostatic Neoplasms

Article	Year
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer. European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:2 Topics: Aged; Antineoplastic Agents; Disaccharides; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Prostatic Neoplasms; Treatment Outcome	2006

Article

Year

A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer.

European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:2

Topics: Aged; Antineoplastic Agents; Disaccharides; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Prostatic Neoplasms; Treatment Outcome

2006